Magdalena Ratajska

1.0k total citations
34 papers, 654 citations indexed

About

Magdalena Ratajska is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Magdalena Ratajska has authored 34 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 18 papers in Genetics and 9 papers in Oncology. Recurrent topics in Magdalena Ratajska's work include BRCA gene mutations in cancer (15 papers), DNA Repair Mechanisms (8 papers) and Ovarian cancer diagnosis and treatment (8 papers). Magdalena Ratajska is often cited by papers focused on BRCA gene mutations in cancer (15 papers), DNA Repair Mechanisms (8 papers) and Ovarian cancer diagnosis and treatment (8 papers). Magdalena Ratajska collaborates with scholars based in Poland, Switzerland and New Zealand. Magdalena Ratajska's co-authors include Janusz Limon, Piotr Kozłowski, Izabela Brożek, Malwina Suszyńska, Irmgard Irminger‐Finger, Maxim Pilyugin, Wojciech Biernat, Maciej Stukan, Magdalena Koczkowska and Åke Borg and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Magdalena Ratajska

33 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magdalena Ratajska Poland 16 379 339 206 189 115 34 654
Alicia Cazorla Spain 11 277 0.7× 302 0.9× 206 1.0× 254 1.3× 30 0.3× 20 639
F Kerangueven France 10 326 0.9× 325 1.0× 164 0.8× 214 1.1× 39 0.3× 15 609
Louise Quenneville Canada 10 290 0.8× 199 0.6× 205 1.0× 165 0.9× 35 0.3× 14 565
John Blondal Canada 8 193 0.5× 286 0.8× 232 1.1× 165 0.9× 35 0.3× 10 594
Carolina Sánchez‐Estévez Spain 10 361 1.0× 72 0.2× 202 1.0× 132 0.7× 167 1.5× 11 661
John Stone United Kingdom 3 427 1.1× 217 0.6× 628 3.0× 110 0.6× 280 2.4× 5 780
Chandramohan S. Ishwad United States 14 311 0.8× 110 0.3× 158 0.8× 132 0.7× 35 0.3× 20 547
Michele Gabree United States 7 215 0.6× 244 0.7× 209 1.0× 160 0.8× 20 0.2× 9 524
Carole Tirapo France 4 342 0.9× 159 0.5× 345 1.7× 156 0.8× 76 0.7× 4 517
Simona Agata Italy 9 224 0.6× 167 0.5× 142 0.7× 79 0.4× 31 0.3× 12 378

Countries citing papers authored by Magdalena Ratajska

Since Specialization
Citations

This map shows the geographic impact of Magdalena Ratajska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdalena Ratajska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdalena Ratajska more than expected).

Fields of papers citing papers by Magdalena Ratajska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magdalena Ratajska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdalena Ratajska. The network helps show where Magdalena Ratajska may publish in the future.

Co-authorship network of co-authors of Magdalena Ratajska

This figure shows the co-authorship network connecting the top 25 collaborators of Magdalena Ratajska. A scholar is included among the top collaborators of Magdalena Ratajska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magdalena Ratajska. Magdalena Ratajska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koczkowska, Magdalena, Maciej Stukan, Dariusz Wydra, et al.. (2023). Analysis of BRCA1 and BRCA2 alternative splicing in predisposition to ovarian cancer. Experimental and Molecular Pathology. 130. 104856–104856. 3 indexed citations
2.
Gimenez, Grégory, Peter A. Stockwell, Peter Tsai, et al.. (2022). Innate immune checkpoint inhibitor resistance is associated with melanoma sub-types exhibiting invasive and de-differentiated gene expression signatures. Frontiers in Immunology. 13. 955063–955063. 22 indexed citations
3.
Ratajska, Magdalena, George A. R. Wiggins, Bożena Cybulska-Stopa, et al.. (2021). Differential Expression of BARD1 Isoforms in Melanoma. Genes. 12(2). 320–320. 4 indexed citations
4.
Pilyugin, Maxim, Magdalena Ratajska, Maciej Stukan, et al.. (2021). BARD1 Autoantibody Blood Test for Early Detection of Ovarian Cancer. Genes. 12(7). 969–969. 5 indexed citations
5.
Wiczling, Paweł, Roman Kaliszan, Michał J. Markuszewski, et al.. (2019). Bayesian multilevel model of micro RNA levels in ovarian-cancer and healthy subjects. PLoS ONE. 14(8). e0221764–e0221764. 6 indexed citations
6.
Brożek, Izabela, Magdalena Ratajska, Magdalena Koczkowska, et al.. (2018). ovarian cancer in a family with coexistence of germline nf1 and brca1 mutations case report. 1 indexed citations
7.
Ratajska, Magdalena, Magdalena Koczkowska, Maciej Stukan, et al.. (2017). Detection of BRCA1/2 mutations in circulating tumor DNA from patients with ovarian cancer. Oncotarget. 8(60). 101325–101332. 36 indexed citations
8.
Pilyugin, Maxim, Magdalena Ratajska, Janusz Limon, et al.. (2016). Antagonizing functions of BARD1 and its alternatively spliced variant BARD1δ in telomere stability. Oncotarget. 8(6). 9339–9353. 9 indexed citations
9.
Klonowska, Katarzyna, Magdalena Ratajska, Izabela Brożek, et al.. (2015). Analysis of large mutations in BARD1 in patients with breast and/or ovarian cancer: the Polish population as an example. Scientific Reports. 5(1). 10424–10424. 24 indexed citations
10.
Kreimann, Erica L., et al.. (2015). A novel splicing mutation in the SLC9A3R1 gene in tumors from ovarian cancer patients. Oncology Letters. 10(6). 3722–3726. 8 indexed citations
11.
Ratajska, Magdalena, Magdalena Matusiak, Bartosz Wasąg, et al.. (2015). Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoforms. Oncology Reports. 34(5). 2609–2617. 15 indexed citations
12.
Irminger‐Finger, Irmgard, Magdalena Ratajska, & Maxim Pilyugin. (2015). New concepts on BARD1: Regulator of BRCA pathways and beyond. The International Journal of Biochemistry & Cell Biology. 72. 1–17. 58 indexed citations
13.
Ratajska, Magdalena, Maciej Stukan, Magdalena Koczkowska, et al.. (2014). Mutational analysis of BRCA1/2 in a group of 134 consecutive ovarian cancer patients. Novel and recurrent BRCA1/2 alterations detected by next generation sequencing. Journal of Applied Genetics. 56(2). 193–198. 18 indexed citations
14.
Brożek, Izabela, Magdalena Ratajska, Magdalena Piątkowska, et al.. (2012). Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases. Familial Cancer. 11(3). 351–354. 20 indexed citations
15.
Ratajska, Magdalena, Anna Piskorz, Izabela Brożek, et al.. (2011). Cancer predisposing BARD1 mutations in breast–ovarian cancer families. Breast Cancer Research and Treatment. 131(1). 89–97. 71 indexed citations
16.
Wierzba, Jolanta, et al.. (2011). Cornelia de Lange syndrome associated with a de-novo novel NIPBL splice-site mutation and a coincidental inherited translocation t(3;5)(p13;q11). Clinical Dysmorphology. 20(4). 222–224. 2 indexed citations
17.
Niedoszytko, Marek, Magdalena Ratajska, Marta Chełmińska, et al.. (2010). The Angiotensinogen <i>AGT</i> p.M235T Gene Polymorphism May Be Responsible for the Development of Severe Anaphylactic Reactions to Insect Venom Allergens. International Archives of Allergy and Immunology. 153(2). 166–172. 10 indexed citations
18.
Brożek, Izabela, Jarosław Dębniak, Magdalena Ratajska, et al.. (2009). Loss of heterozygosity atBRCA1/2 loci in hereditary and sporadic ovarian cancers. Journal of Applied Genetics. 50(4). 379–384. 7 indexed citations
19.
Brożek, Izabela, Jarosław Dębniak, Magdalena Ratajska, et al.. (2007). High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland. Gynecologic Oncology. 108(2). 433–437. 44 indexed citations
20.
Brożek, Izabela, Jarosław Dębniak, Maciej Stukan, et al.. (2006). HER2 Amplification Has no Prognostic Value in Sporadic and Hereditary Ovarian Tumours. Hereditary Cancer in Clinical Practice. 4(1). 39–42. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alicia Cazorla Breakdown of academic impact, for papers by F Kerangueven Breakdown of academic impact, for papers by Louise Quenneville Breakdown of academic impact, for papers by John Blondal Breakdown of academic impact, for papers by Carolina Sánchez‐Estévez Breakdown of academic impact, for papers by John Stone Breakdown of academic impact, for papers by Chandramohan S. Ishwad Breakdown of academic impact, for papers by Michele Gabree Breakdown of academic impact, for papers by Carole Tirapo Breakdown of academic impact, for papers by Simona Agata
Rankless by CCL
2026